Analiza Sociedad De Diagnostico SL.

Analiza Sociedad De Diagnostico SL. is a for-profit corporate entity registered to receive awards from the U.S. federal government since January 9, 2019. The company specializes in providing laboratory testing services to various defense agencies within the federal government. Analiza Sociedad De Diagnostico SL. has demonstrated expertise in conducting crucial medical tests, particularly those related to infectious diseases. The company's registration in SAM.gov is current and set to expire on March 13, 2025, indicating its ongoing eligibility to receive federal contracts.

The recent federal contract awards to Analiza Sociedad De Diagnostico SL. showcase its focus on providing specialized laboratory testing services to defense agencies. The company's most recent and largest contract, awarded on April 2, 2024, by the Bureau of Medicine and Surgery, is a firm fixed-price purchase order for laboratory testing services with a ceiling value of $231,929.43. Prior to this, Analiza Sociedad De Diagnostico SL. was awarded contracts specifically for COVID-19 related testing. In November 2020, the Naval Supply Systems Command awarded the company a contract for PCR testing for SARS-CoV-2, with a ceiling value of $22,276.68. Earlier, in May 2020, the Defense Health Agency contracted the company for SARS-CoV-2 antibody (IgM/IgG) tests, with a ceiling value of $20,070.77. These contracts demonstrate Analiza Sociedad De Diagnostico SL.'s capability to provide critical laboratory testing services during public health emergencies. Notably, none of these contracts were associated with any set-aside designations, indicating that the company competed for these contracts in the open market.